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Many changes have taken place in  
the research offices at the University  
of Arkansas this past year. Collis Geren, 
who served for many years as vice provost 
for research and dean of the graduate 
school, has retired. Because the university 
has grown so much, it was decided that 
the two titles would be separated into  
two different positions. Because of this 
change, the Office of Research has 
become the Office of Research and 
Economic Development.
The university has made great strides  
in recent years in creating companies  
in Arkansas based on technologies devel-
oped on our campus, and that progress 
generated the need to add economic 
development as a component of this 
office. This will allow the institution to 
capitalize on the intellectual property 
developed by university faculty and help 
license that technology to start-up com-
panies. It also means encouraging the 
growth of companies in our own “back 
yard” and providing companies every-
where in Arkansas with the things that 
they need to be successful. 
We have excellent facilities to assist with 
this, in the form of Genesis, a company 
incubator for fledgling companies, the 
Innovation Center, for small businesses 
that need a little more room, and finally 
the Enterprise Center, where businesses 
can expand their research and develop-
ment laboratories to scale up their work.
To enhance our support of economic 
development, Carol Reeves has been  
promoted to associate vice provost for 
entrepreneurship. For many years, she  
has successfully advised students creating 
business plans for competitions, and she 
has helped many entrepreneurs at the 
institution and within the state. 
In her new position, she will help  
create companies that will have jobs for 
our graduates so that they can stay in  
the state of Arkansas. 
Governor Mike Beebe believes that job 
growth and education are inseparable, 
and that the way for Arkansas to succeed  
is to develop our knowledge-based econ-
omy. By expanding our role in economic 
development through research-based 
technologies and breakthroughs, we are 
helping to fulfill that mission.
On the research side, we have under-
gone some changes to make it even easier 
for faculty to move grants through our 
operation. Dennis Brewer, the new direc-
tor of research support and sponsored 
programs, will work with faculty members 
to facilitate the grant process. We have 
created an associate deans’ committee 
to keep the dialog between the office 
of research and the colleges open at all 
times, and we also meet with the deans 
periodically.
We have made changes to our research 
compliance office and our office that 
looks at human and animal use and proto-
cols. We’re centralizing our information in 
the area of regulations so that it is easy for 
people to find information. 
All of these changes will help us con-
tinue to improve the way we support the 
dynamic research culture on this campus. 
 By Jim Rankin
  Vice Provost for Research and 
Economic Development
Chancellor
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By Loreal Robertson
As an undergraduate piano performance major, Amy 
Herzberg spent many hours practicing alone. But because 
she enjoyed the collaborative efforts of theater, Herzberg 
decided drama was something she “couldn’t live without.” 
She describes her involvement in theater as having no true 
“beginning” but rather as something that “just was.” Since 
then, the University of Arkansas professor of drama has 
been actress and director for several plays, including Dirty 
Rotten Scoundrels, Doubt and Cabaret. 
“In several productions I’ve been involved in, I’ve gotten 
letters afterwards, and people have come up to tell me that 
it has in some way changed their life,” she says.
Herzberg thinks of theater as a form of art that “accesses 
our own hearts.” Its purpose is to tell the story of what it 
means to be a human being, to touch lives and inspire 
individuals to make changes. Its subject is always humanity 
and often creates an emotional response in its audience 
whether happy or sad. As performers, “we hope to touch 
and open the hearts of people who are seeing theater, in a 
way where they can take on any aspect of what it means to 
be a human being and truly examine it,” Herzberg says. 
She quotes playwright David Mamet, who said, “Theater 
is one of the last places where a group of people can come 
together to hear the truth.” She believes in the value of  
theater and that human nature has the desire to learn 
through story telling, especially when that story has  
something meaningful to say.
Herzberg also directs musical theater, combining  
dialogue, songs, and dance. Typically, composers of  
musicals follow traditional rules; others abandon these 
rules and are responsible for creating new advancements. 
“Stephen Sondheim broke, even changed many rules,” 
Herzberg says. “He created a whole new way to experience 
musical theater.”
Whether it is a musical, a comedy or a tragedy, theater 
“allows you to examine the truth in very difficult situations.” 
Being in the audience and observing the elements in a  
performance “you’re sitting in a communal space with 
other people who in their hearts are undergoing similar 
feelings,” she says.
Herzberg examined some of her own truths in 2008 
when she starred in a play titled My Father’s War, which 
premiered at TheatreSquared in Fayetteville, Ark. Written 
by her husband, Robert Ford, the play tells the story of 
her father, Arthur Herzberg, and his difficult experiences 
in World War II. He went to see the play for several nights 
and would cry during the scene when a man named Bobby 
Harricausen was killed in the very foxhole he just stepped 
out of to go get their lunches. Eventually the crying less-
ened, and he told his daughter that it really helped him to 
see the play. “The fact that my father has been personally 
in some way made happier by something that happened in 
that way: I’m sure you could imagine the layers of meaning 
it has to me.” 
In the play, she portrayed the roles of both herself and 
her 19-year-old father. “I’ve never had a role that required 
more of me or gave more back to me,” she says. “It was an 
amazingly special event.” n
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Combining Salt with Heat Shows 
Way to Reduce Salmonella 
Poultry processors trying to keep Salmonella off their products 
may have a new procedure at their disposal: add some salt and 
turn up the heat. It’s more complex than that, but it’s the key 
point of recent research by Sara Milillo, a postdoctoral research 
associate in food science at the University of Arkansas Division of 
Agriculture. 
“Our goal is to come up with a multiple hurdle treatment where 
we combine things to help prevent bacterial resistance by using 
different treatments that attack different functions or parts of the 
cells simultaneously,” Milillo explained.
Milillo’s study, published in the Journal of Food Science, examined 
the application of heat plus an organic acid salt solution to reduce 
Salmonella on chicken. The combined treatment lowered the 
amount of pathogen, leading Milillo to conclude that it may rep-
resent an effective method for decontaminating poultry carcasses 
during processing.
Milillo also tried heat and salt treatments separately and found 
that neither one could do the job alone. 
She ran the experiments using chicken juice, a raw chicken 
model medium, rather than chicken carcasses. The results tell 
enough of a story to draw valid conclusions, but more information 
will be available by using chicken carcasses.
 “We’re hoping the chicken juice gets us a step closer to an 
actual raw poultry system,” Milillo said. “But by using chicken  
juice initially we can screen lots of treatments and narrow down 
what’s the most effective before we go into a more costly use of 
actual carcasses.”
Milillo and industry personnel have reviewed processing pro-
cedures that could be adapted to the research findings. Heated 
washes are used to clean carcasses, so a salt additive in a heated 
rinse might be one place to implement new methods. n
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Probe Used to Determine  
Efficacy, Toxicity of HIV Drugs
A biomedical engineer has developed a molecular probe  
that can simultaneously detect the presence of HIV-1 protease  
and toxicity levels of chemical compounds 
used to combat the deadly virus that causes 
AIDS. The probe can be used to investigate 
the efficacy and efficiency of HIV drugs, some 
of which are so toxic that many patients elect 
to stop treatment.
“Because our screening system detects bio-
chemical activity related to HIV and the toxic-
ity of drug compounds at the same time, it can 
be used to determine whether a given combi-
nation of drugs is effective,” said Sha Jin, assis-
tant professor in the College of Engineering. 
“The ultimate goal is to identify more effective 
and affordable drugs to treat HIV.”
Although it is currently incurable, HIV can 
be controlled by anti-HIV drugs, which sup-
press or inhibit virus replication in patients. Currently, treatment 
of HIV infection depends upon a strategy called highly active 
antiretroviral therapy, in which drugs that inhibit HIV-1 prote-
ase – a family of enzymes essential for the life cycle of HIV – are 
combined with drugs that suppress virus replication. Although 
the therapy has reduced mortality, it has side effects. A quarter of 
patients with HIV stop therapy within the first year due to symp-
toms related to its high toxicity.
To address this issue, Jin created a screen-
ing system by applying fluorescent proteins, 
one green and one red, to generate Förster 
resonance energy transfer signals responsive to 
HIV-1 protease inhibition and activity. Förster 
resonance energy transfer is a mechanism of 
energy transfer between a donor and receptor 
chromophore, the part of a molecule that is 
responsible for its color. The energy transfer 
prompts reactions from cells in the form of 
color. In the absence of protease inhibitors, 
the researchers observed green and yellow 
cells. When protease inhibitors were added to 
cells, they showed a red color.
“We confirmed that compounds nelfinavir 
and lopinavir were toxic to cells, since many 
healthy cells died after two days incubation,” Jin said. “Indinavir, 
sequinavir, and ritonavir showed less toxicity.” n
This image illustrates HIV-1 protease 
activity detected by Sha Jin’s molecular 
probe.
Post-doctoral research associate Sara Milillo streaks plates on which 
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Teeth Tell Tales 
See select images of illustrations drawn 
by a professor for his book on the origin 
of mammal teeth.
Big on the Little Things 
A local company uses nanotechnology 
developed at the university to provide 
solutions to societal problems.
A Celestial Celebration 
The Arkansas Center for Space and 
Planetary Sciences celebrates 10 years.
Wild Things in the Water 
Two students in biological sciences study  
the ebb and flow of watersheds in the region. 
They also look closely at the spineless crea-
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Research took a step toward understanding hypertension in 
women by using a new technique to examine the release of a  
neurotransmitter in small blood vessels. 
After menopause, women have an increased risk of hyperten-
sion, and among older adults, more women than men have  
hypertension. Yet, research in hypertension has focused on males, 
and little is known about how women’s bodies manage blood flow.
“The answer to why women have more problem with hyper-
tension seems to be in the synapse,” said exercise scientist Heidi 
Kluess. 
The synapse is the space between the nerve and the vascular 
smooth muscle, the place where the nerve and blood vessel inter-
act. A neurotransmitter crosses the synapse to activate a receptor, 
which then causes the artery to constrict.
“There’s been a little evidence to say that some of the neu-
rotransmitter breakdown is different in women. It suggests that 
when we’ve been looking at receptors on the smooth muscle, 
we may have been missing a big part of the story, particularly in 
women,” Kluess said. “That’s where I started from.”
Kluess measured the neurotransmitter adenosine triphosphate 
(ATP) coming from the small blood vessels known as arterioles. 
ATP plays a key role in controlling blood flow and blood pressure 
by causing the diameter of blood vessels to change. Thus, the  
constriction of veins associated with hypertension could be related 
to relatively high levels of ATP in arterioles.
Kluess’ first set of questions were aimed at understanding where 
the ATP comes from, what tissues are releasing it and how this 
changes with aging. 
The researchers found that ATP is released mostly from the 
sympathetic nerves in the arteriole wall and that only a small part 
comes from the smooth muscle
They also found that the ATP overflow varied considerably with 
age. Because ATP is associated with vascular growth, it is impor-
tant during early development when blood vessels are growing, 
but levels generally decline when people reach their twenties. 
Elevated levels can be a bad sign during aging and may be a  
predictor of vascular changes that can be detected years before 
hypertension is a problem. n
Virtual Reality Gives 
Insight on 3-D  
Protein Structures
To understand a protein, it helps to get 
inside of it, and a biochemistry professor 
has figured out a way to do so.
James F. Hinton, University Professor  
of chemistry and biochemistry, worked 
with Virtalis, an advanced visualization 
company, to create a computer software 
program and projection system that lets 
researchers look at larger-than-life, 3-D 
structures of proteins in virtual real-
ity. This allows scientists to walk inside, 
through or around a protein to investigate 
its structure and function.
“Proteins are very complex molecular 
structures,” said Hinton. Proteins are built 
from amino acids, molecules that share 
certain characteristics and have unique 
side chains. Yeast proteins can have 466 
amino acids, while the larger proteins 
have almost 27,000 amino acids. These 
amino acids interact to form a structure 
for each protein, and this structure helps 
determine the protein’s function.
Since proteins underlie most human 
diseases, they interest researchers study-
ing the mechanisms of disease. The flu 
virus, for instance, harbors proteins that 
cause the illness experienced by humans. 
Figuring out how to neutralize these pro-
teins could help treat or prevent disease.
Examining protein interactions in two 
dimensions ranges from tedious to  
impossible because of the proteins’ 
size and complexity. This system allows 
researchers to enlarge proteins to room-
size and examine them from all sides, 
including the inside. 
“Using this system, we can answer many 
questions about interactions. Why does a 
toxic protein do what it does? Does the 
protein form a channel? If it does, what 
does it look like? And how can we block 
it?” Hinton said. “This system can act as a 
guide for what to do next.” n
‘Blockbuster’ Exhibit Imagines 
Increased Housing
Carl Smith wonders how continued population growth will 
make northwest Arkansas look in 40 years. In order to imagine it, 
he’s created an exhibition with thousands of tiny, wooden boxes.
Smith, assistant professor of landscape architecture, created this 
exhibit with Bethany Springer, assistant professor of art. Smith’s 
idea is rooted in an exhibition he saw by West 8, a renowned 
Dutch urban design and landscape architecture firm, which used 
tiny wooden houses to prompt discussion about the housing 
boom in the Netherlands.
He wondered if something similar would work for north-
west Arkansas. The result is an interactive exhibition titled 
“Blockbuster: Imagining a Future Fabric for Northwest Arkansas.” 
It’s easy to toss out numbers, like the 37,500 new homes 
expected in Fayetteville by 2050, or even the estimated 25,000 for 
Bentonville in that time.
“Those numbers don’t really mean that much unless you can 
demonstrate to people what that actually looks likes,” Smith said.
So those homes are represented by tiny wooden pieces, each 
approximately 1-inch long and a half-inch deep and tall. On a 
scale where an inch represents 45 feet, these wooden “homes” 
stand in for roughly 2,000-square-foot homes.
Smith, who’s from England, said that country covers about as 
many square miles as Arkansas, yet Arkansas has a population of 
just about 3 million compared to England’s 51 million.
“When you’ve got so much land, it’s difficult to perceive there 
being a problem,” he said. “I think that underscores a lot of the 
sprawl that’s occurred in the U.S.” n
Peripheral Developers Increase 
Product Quality
An information systems researcher has found that peripheral 
developers – those outside the core development team – make 
important contributions to product quality and significantly  
influence product awareness and adoption.
“Our interviews suggest that peripheral developers are very 
active promoters of the products they’re involved with,” said 
Pankaj Setia, assistant professor in the Sam M. Walton College of 
Business. “Using personal channels such as blogs and websites, 
these volunteer developers associate their identities with these 
products, and in this process, they become the ideal product  
emissaries. Working outside the traditional software development 
paradigm, they have greater credibility with potential consumers.”
Open-source software development is based on the community 
paradigm in which source code for software is available for any-
one to study, change and improve. In contrast to the proprietary 
approach, open-source development relies on ideas from external 
developers and prospective users.
Examples of open-source software products include content-
management systems such as Drupal, Joomla! and MySQL. The 
popular Web browsers Mozilla Firefox and Google Chrome began 
as open-source software products.
Setia and his colleagues used longitudinal data from 147  
open-source software products. The researchers asked, among 
other things, if peripheral developers have a positive impact on 
product dissemination. 
The results showed that peripheral developers served as sources 
of information to enhance product awareness and adoption. This 
occurred through word-of-mouth via blogs, websites and other 
online communities. Setia said software firms should not underes-
timate the significance of this finding.
“Our study has important implications for marketing managers 
at firms espousing open innovations,” he said. “The peripheral 
participants may be an important way for marketing managers to 
bridge different types of product promotion. In other words, they 
may not have to choose between mass advertising and the more 
personalized effect of promotion via word-of mouth.” n
Virtual reality allows scientists to gain insight into protein structures from the inside out.


















7Spring 2011Research Frontiers6 Spring 2011Research Frontiers
University of Arkansas 
Student Research
University of Arkansas 
Student Research
For almost a decade the war in the Middle East has been in  
full force. Countless news entities have given the world a dose of 
the chaos millions undergo, but through the media we only learn 
a thin layer of the reality. While many of us are chatting with an 
old friend on Facebook or enjoying a relaxing jog at the park,  
the lives of thousands of soldiers are either ending abruptly or  
are spiraling down a black hole that will take them to a state of 
physical, emotional and psychological trauma beyond what they 
ever imagined. 
Some research has torn down the walls surrounding the impact 
the war has had on soldiers. However, most of the research con-
ducted has been centered on males and their specific ways of 
adaptation to trauma and physical disabilities. 
Although women have been in active duty for years, the Iraq 
and Afghanistan wars are the first time all deployed servicewomen 
are in combat zones doing the same jobs as men. Over 1,200 
American service members have lost limbs as a result of these 
wars, yet there is little research, especially on women, on how they 
are adjusting to life without one or more limbs. 
As part of her dissertation, University of Arkansas doctoral grad-
uate Janet Cater interviewed six women amputees to learn about 
their psychosocial adjustment to the loss of one or more limbs. 
“There is little research on the psychosocial adjustment of 
women to amputation. As more and more American service-
women receive combat injuries, such as amputation, it is critical to 
understand how they adjust to limb loss,” Cater says. 
Over the course of about five months Cater researched and 
wrote her doctoral dissertation on their physical, emotional and 
psychological challenges. The women ranged in age from 20 to 
36 at the time of injury. Five of the women were injured by either 
a rocket propelled grenade or an improvised explosive devise 
while in combat. Two women lost both legs, one woman lost one 
leg above the knee, one lost an arm and the other both arms. 
The sixth woman Cater interviewed had a leg amputation after a 
motorcycle accident and later served on a tour of duty in Iraq on 
a prosthetic leg. 
Through phone conversations and interviews on Skype, she 
learned why these women chose to serve in the military and how 
their lives changed after their injuries.
She discovered that these women had a “kick-butt” attitude pro-
moted by the military environment around them and that their 
recovery was influenced by the belief that their loss had meaning. 
The fact that their amputations occurred while protecting their 
country and freedom helped them cope with their injuries. For 
these women their loss of limb was a badge of honor of their  
service to the country that is usually ignored by the public. 
Cater stated that while servicemen amputees are often thought 
to have received their injuries due to war, society does not accord 
the same recognition to servicewomen.
 “If a young man goes out in public after suffering an amputa-
tion, people automatically think it was because of military duty 
and so he gets praised,” Cater says. But women often experience 
disbelief.
“People don’t tend to believe that these women perform the 
same duties as men and that they too can get hurt,” Cater says. 
“One of the women I talked to told me she makes up stories 
about how she lost her arms because many people don’t believe 
she received those injuries as an explosive ordnance disposal  
technician in the Iraq War.”
The message all six women want to deliver through this 
research was that they would like to be appreciated for their 
service just as much as men are. Cater says that the disbelief the 
women receive is very disappointing, because they feel they too 
deserve respect and appreciation for their military efforts.
Through her study, Cater learned that these women have a high 
amount of resiliency. They all used humor and personal courage 
to cope with the changes life threw at them. Adaptation is the key 
to living everyday to the best of their abilities. 
“One of the ladies can actually beat her husband in videogames 
while using her toes to work the controller,” she says. 
With positive outlooks on life, these women are actively pursu-
ing their goals with determination. Three are currently employed. 
One is taking her boards to become a prosthetist to help women 
in situations similar to hers regain confidence and control of their 
lives, and the remainder are either enrolled or planning to attend 
college. Two women continue to serve in the military: one has 
applied to become a helicopter pilot and the other turned down 
full medical retirement to continue to serve.
The six women that Cater got to know are only a few of the 
many that risk their lives for the safety of Americans. Over 220,000 
servicewomen have fought in name of the United States since 
the beginning of the war: 130 of have died, over 600 have been 
injured and about 24 have lost one or more limbs. 
The strength of these servicewomen as well as their unwavering  
pride amazed Cater. They chose to share their stories to help 
future servicewomen amputees and to advocate the great  
need for support and care for women who are experiencing the 
same struggles.
“It makes you put things in perspective. For these women  
every day is a struggle to adapt to the loss of limb. It makes you 
appreciate the ability to accomplish simple tasks simply because 
you have all of your limbs intact,” Cater says. n
Magnifying A Distinct 
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The Arkansas Research and Technology Park helps 
researchers take their innovations and make them 
into products that benefit society.
A lab on a chip, nanocrystals in solution and miniaturized 
power modules probably don’t mean much to the average person. 
But testing for traumatic brain injury on the spot, developing 
more energy-efficient lighting and more economical hybrid  
electric vehicles might, and that’s exactly what each of the  
innovations above has become, thanks to the hard work of 
many scientists and support from the Arkansas Research and 
Technology Park. The following pages contain three profiles of 
up-and-coming companies in different stages of creating products 
based on research findings.
Growth in the Arkansas Research and Technology Park has 
exploded: The Innovation Center, built in 2004, has 35,000 square 
feet of space. Six years later, the Enterprise Center has opened 
with 60,000 square feet of space that can accommodate offices 
as well as wet and dry laboratories. Together these two centers 
facilitate the commercialization of research and will be useful for 
companies that are just beginning to grow.
The three companies featured here, as well as NanoMech 
and Duralor, featured in a video on the Web, represent the first 
tenants of the new building – merely the beginning of a period 
of growth for technology businesses in Arkansas. The possible 
economic impact of companies within the Arkansas Research 
and Technology Park could be up to $134 million over the next 
five years, according to a report by the University of Arkansas 
Technology Foundation.
“It has been very gratifying to see the evolution of these compa-
nies, as it represents a fulfillment of our strategic plan,” said Phil 
Stafford, president of the foundation. “The path to commercial-
ization is neither quick nor easy, but through the development of 
an innovation system consisting of facilities, equipment, workforce 
and the culture necessary for product development, the founda-
tion is reducing the barriers that exist between idea generation 
and product launch.”
A Company is BornbusinessHow an idea becomes a











By Melissa Lutz Blouin
SFC Fluidics
Arkansas Power Electronics International
Scientists have long wanted to make small “laboratories” – hand-
held devices that allow researchers to perform tests on the spot, 
in the field. SFC Fluidics has taken technology to do that and 
applied it to the real-world problem of traumatic brain injury.
“A person will be able to take a tiny blood sample, much like 
one might for a diabetic blood sugar test. They’ll insert the  
sample into the device, and it will indicate if a traumatic brain 
injury has occurred and how severe it is,” said Forrest Payne, 
senior scientist for the company. The company got a $5 million 
grant from the U.S. Armed Forces for a four-year project to create 
this device using technology licensed from various institutions. 
“It’s a great opportunity to help people who potentially have 
these injuries,” Payne said.
The company is in the first year of the four-year grant. They 
have developed the pumps and the miniaturized capabilities  
as well as the connections for the device, and currently they’re  
building the prototype.
Payne returned to Arkansas after getting his graduate degree 
from the University of Virginia. He got his undergraduate  
degree in physics at the University of Arkansas and his parents  
live in the area. He wanted to move back to the area, but jobs  
for physicists are scarce in Arkansas. SFC Fluidics provided him 
with the opportunity to return to Arkansas with a good job.
“It’s kind of a Cinderella story,” said Sharmilla Mounce, 
business operations manager for Arkansas Power Electronics 
International, Inc. In 2002 she and Alex Lostetter, chief executive 
officer of the company, worked for free for a year and maxed out 
their credit cards to start the company with former colleague Jerry 
Hornberger. Today the company has 30 employees and $3 million 
in revenue, but for a short time it looked as if the company would 
go nowhere at all. Grant money appeared just a week before 
Lostetter left for a paying job.
“We all wanted to be in Arkansas, but there aren’t a lot of high-
tech jobs here,” Mounce said. 
The company grew by capitalizing on technology to make 
things smaller – in this case power modules used in vehicles, 
geological exploration and the aerospace industry. To shrink the 
size of such devices, company scientists have focused on silicon 
carbide. Silicon carbide can operate at temperatures up to 600 
degrees Celsius, unlike other currently used materials, which  
operate at about 125 degrees Celsius.
“If you can have electronics operate at higher temperatures,  
you need less of a cooling system,” Mounce said. 
With their first grant in hand, the engineers took the unusual 
step of creating a motor drive from scratch to demonstrate that 
their concept would work. 
“We grew everything from the ground up, from the sweat that 
people put into the company,” said Lostetter, and the work paid 
off. They kept that first motor drive as a reminder of how they 
started. It has a place in the same room with the R&D 100 maga-
zine’s award for their work on a state-of-the-art power module.
A joint development between APEI, the university, Rohm 
Company LTD., and Sandia National Laboratory, the APEI power 
module is the world’s first commercial high-temperature silicon 
carbide-based power electronics module. With applications in 
hybrid and electric vehicles, renewable energy and electric air-
craft, the APEI power module reduces size and volume of power 
electronic systems by an order of magnitude over present mod-
ules. It also reduces energy loss by greater than 50 percent, which 
translates into significant potential energy savings.
They have worked with a major aeronautics company to put 
wireless sensors on turbine blades to monitor them for vibrations. 
The tips of these blades can heat up to about 500 degrees, so 
silicon carbide can effectively work for these sensors where other 
materials will not. 
Based on these and other successes, the offices for APEI have 
expanded from a 150-square-foot room to 10,000 square feet of 
research and development space and 10,000 square feet of manu-
facturing space in the new Enterprise Center, which opened in 
October. 
“We’ll be able to take things from an actual concept all the way 
to a product,” Mounce said. 
The company has not sought venture capital to grow; instead, 
the company is employee owned. 
“That’s a challenging way of doing things,” Lostetter said. 
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From left. David Battaglia of NN-Labs, Sharmila Mounce of 
Arkansas Power Electronics International and Forrest Payne of 
SFC Fluidics all live in Arkansas thanks to jobs at businesses 













“It also lets us go where we think we ought to go” in terms of 
research and development.
Of their 30 employees, 23 have bachelor’s degrees and three 
are pursuing their bachelor’s degree. Seventeen people have or 
are pursuing degrees beyond a bachelor’s degree. And most of 
these employees either have a degree or are pursuing a degree at 
the University of Arkansas. The company’s policy of supporting 
employees in furthering their education, plus flexible work hours, 
free health club memberships and a commitment to work-life  
balance helped the company win the Silver Award for small  
companies in the Governor’s Work-Life Balance competition.
“It all comes down to having good people,” Lostetter said.
NN -Laboratories
In 2002, Xiaogang Peng, a professor of chemistry and bio-
chemistry, synthesized nanocrystals in suspension using environ-
mentally friendly methods that had not been seen before. Shortly 
thereafter, he founded a company at the Arkansas Research  
and Technology Park to examine possible applications for these 
nanocrystals. 
Peng recently returned to China, but the company he founded, 
NN-Laboratories, continues to do research and development in 
Fayetteville. The company also has a subsidiary called NN-Crystal 
that specializes in applying the technology to lighting.
The nanocrystals can power solid-state lighting used commer-
cially. Lighting consumes more than 20 percent of the energy 
used worldwide, and most current light sources are inefficient: 
An incandescent light bulb is about 1-3 percent efficient, while 
fluorescent light bulbs are about 20 percent efficient. In contrast, 
solid-state lighting, also known as LED lighting, can be up to 50 
percent energy-efficient. Furthermore, this LED lighting lasts 
much longer than standard bulbs: Incandescent bulbs last about 
six months, fluorescent bulbs anywhere from a few months to 
three years, and LED lighting can last up to 10 years.
“Imagine a hotel lobby in Las Vegas. There, the cost of a  
light is trivial compared to the cost of replacing those lights,” said 
Suresh Sunderrajan, president of NN-Crystal.
Despite their increased efficiency, LEDs have proved a chal-
lenge, because they are monochromatic — they do not emit white 
light, which is a combination of all types of light. Instead, they 
can only emit colors like red, blue and yellow. LEDs are made 
to produce white light by combining a blue LED with a yellow 
phosphor, a substance that glows when exposed to electrons. The 
combination of blue and yellow makes white. The quality of white 
light produced this way is poor, however, with relatively poor color 
rendering ability. 
“This can cause a blue jacket to look gray, for instance,” 
Sunderrajan said. High-quality light mimics sunlight, the human’s 
natural standard, and the light from LEDs is not considered to 
be of high quality unless other colors beyond blue and yellow are 
added, which cuts back on the light’s overall efficiency – the light 
may look better, but the amount of light emitted is lower for the 
same amount of energy.
“We fix that problem with our technology,” Sunderrajan said.
NNCrystal has created a technology called Qshift Coral,  
which uses quantum dots to precisely control color. They can  
be used to augment the color of light emitted by LEDs to  
produce high-quality white light without sacrificing efficiency. 
Since these quantum dots are tunable – the optical properties  
can be controlled to change the color of light they emit – the 
lights can be “tuned” to create almost any other color or color 
combination on the spectrum.
The second technology being introduced by NNCrystal,  
Qshift Lucid, features nanoparticles that are color-free in  
ambient lighting and can be combined with different LED  
lights, yet will look clear like traditional lights when turned  
off. This technology can be used to build all of the colors in  
the sun’s spectrum.
“It’s just like having the sun indoors,” Sunderrajan said. 
The company demonstrated the technologies at Lightfair  
2010, the lighting industry’s trade show. Their technology  
caught the interest of Renaissance Lighting, a company that  
was recently bought by Acuity Brands, which has about $1.6  
billion in annual sales.
Qshift Coral is available commercially now, and Qshift Lucid 
should be available next year.
The company employs 15 people, four of whom have doctoral 
degrees in optical physics, polymer engineering and synthetic 
chemistry. 
“The focus of the Arkansas lab is taking an idea from its  
synthesis to proof of concept,” Sunderrajan said.
Beyond lighting, NN-Labs is looking at advanced applications 
in the life sciences, such as medical diagnostics, as well as possible 
use to enhance the performance of solar cells.
Point your smart phone here to see a video about another  
company in the Arkansas Research and Technology Park. n
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By Matt McGowan
This story begins in 2004, when Jeffrey Schlom, chief of the 
Laboratory of Tumor Immunology and Biology at the National 
Cancer Institute in Bethesda, Maryland, took a risk and hired an 
engineer with no immunology experience. Though it was a bold 
move, it also made sense, because the investigators in Schlom’s 
lab are trying to develop vaccines and immunotherapies that can 
be moved from the laboratory to human clinical trials in no more 
than 10 years. Researchers call it “bench to bedside,” and when 
the emphasis is on saving lives tomorrow, sometimes calculated 
risks are in order.
David Zaharoff, the first engineer ever to work in the tumor 
immunology and biology lab at the National Cancer Institute, had 
just finished a one-year postdoctoral fellowship at Duke University, 
where he had received his doctorate in biomedical engineering. 
While there, Zaharoff had worked on methods to improve the 
way pieces of DNA are delivered within the human body for gene 
therapy applications. Some of this investigation involved physical 
mechanisms, and some of it involved biomaterials. 
During this period Zaharoff became interested in immune 
responses, a curiosity that would steer him toward the job at the 
National Cancer Institute. He attended numerous conferences  
at which investigators talked about the potential of new delivery 
systems for gene therapies and drugs. However, he became  
frustrated by the lack of research on how these new delivery  
systems would be recognized by the immune system.
“At these conferences, the emphasis was always on the effect  
of this or that drug or gene therapy, but immune response was  
left out,” Zaharoff says. “Every single drug or gene delivery  
system placed in the body will generate an immune response for 
better or for worse. I felt my career was going to be limited unless 
I understood the nature of these immune responses.”
Floundering Around
In Schlom’s lab, Zaharoff had some catching up to do. 
Compared to other investigators, he entered with a limited back-
ground in immunology. But Schlom and others were patient. 
They gave him time to learn their field. Zaharoff describes this 
period as “floundering around,” but he knows it was anything but.
“I spent those years learning about immunology,” he says. “Here 
I was, an engineer working with a bunch of classically trained 
immunologists. It was a bit like learning a foreign language in a 
country where no one speaks English. So I studied the evolution 
of cancer vaccines and immunotherapies, and I realized that no 
one really focused on the delivery aspects of cancer vaccines.”
After two years of “floundering,” Zaharoff found his niche. 
He realized that cancer vaccines and immunotherapies could be 
made more effective if they were delivered to the right place, at 
the right time and at the right concentration in the human body. 
In short, there was a delivery design problem. As an engineer, that 
was exactly what he needed.
Lobster Power
Zaharoff concentrated his efforts on developing safe and 
efficient means to localize therapeutic cytokines – proteins that 
produce an immune response – to make vaccines and immuno-
therapies more effective. Controlled- or extended-release delivery 
systems had been explored in drug delivery for decades, but these 
systems were unlikely to work with proteins because the systems 
used harsh chemicals that could destroy proteins.
From Bench to Bedside:
Research Shows Promise
In Treatment of Cancers
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In 2009, David Zaharoff came to the University of Arkansas after sev-
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One day, Zaharoff read an article about chitosan, a polysac-
charide derived from the shells of crustaceans such as shrimp 
and lobsters. Chitosan had been evaluated for use in studies on 
a wound dressing, a weight-loss supplement and a nasal-delivery 
system. In chitosan, Zaharoff thought he might have found what 
he was looking for – a biomaterial that could be used to hold and 
slowly release cytokines nearly anywhere in the body. Chitosan 
satisfied his short list of criteria for an ideal delivery system. It was 
a biocompatible and biodegradable substance that did not require 
harsh organic solvents. In two early publications, Zaharoff showed 
that chitosan could indeed enhance immune responses and 
increase the effectiveness of cytokines.  
Almost Fell Off the Planet
In 2006, Zaharoff began a fruitful collaboration with John 
Greiner, staff scientist and head of the cytokine working group 
within the Laboratory of Tumor Immunology and Biology. As 
Zaharoff focused on delivery systems in general and chitosan  
specifically, Greiner shared his expertise in cytokine biology. 
After the initial publications on chitosan, Zaharoff and Greiner 
wondered if they could deliver any cytokine to any location in the 
body. If so, which cytokine would work, and where would they 
put it? Interleukin-12 (IL-12) immediately came to mind. IL-12 is 
a powerful cytokine that stimulates the body’s immune system to 
attack a range of cancerous tumors. It had been effective in  
animal studies, but severe toxicities in human trials ceased its  
commercial development. Greiner had worked with IL-12 in the 
early 1990s and still had some in a freezer.
“I knew that due to toxicity problems, IL-12 had killed a couple 
patients in clinical trials in the mid ’90s,” Zaharoff says. “Since that 
time, it had been out on the fringe. No one really wanted to touch 
it. It almost fell off the planet. But this wasn’t because IL-12 was a 
bad drug; we just weren’t delivering it in the right way.”
The Bladder Study
“We tried a lot of different combinations of antigens and  
cytokines with chitosan,” Greiner says. “In the end, IL-12 won  
the contest.”
While experimenting with the two substances, Zaharoff and 
Greiner met Benjamin Hoffman, a post-baccalaureate fellow who 
was “on loan” from the NCI’s Urologic Oncology Branch because 
he wanted to work with vaccines. Hoffman wanted to test some of 
the tumor immunology and biology lab’s vaccines on superficial 
bladder cancer. Zaharoff and Greiner decided to collaborate with 
him and try the chitosan/IL-12 mix on that type of cancer.
Both Greiner and Zaharoff emphasize the importance of work-
ing within a group of labs. It was this fact, more than the nature of 
the research itself, that led to the collaboration with Hoffman. In 
other words, Zaharoff and Greiner did not co-formulate chitosan/
IL-12 specifically for superficial bladder cancer.
“Chitosan/IL-12 was designed for direct injections of solid 
tumors,” Zaharoff says. “In retrospect, it made perfect sense to 
instill it in a bladder.” 
Each year, approximately 70,000 people in the United States 
are diagnosed with bladder cancer, and slightly more than 15,000 
people die due to the disease. 
For many decades, a drug known as BCG (bacillus of calmette-
guerin, a type of bacteria) has been the standard-of-care  
immunotherapy for superficial bladder cancer, which leads to 
muscle-invasive and then metastatic bladder cancer. However, a 
high percentage – 20 to 30 – of patients fail initial BCG therapy, 
and 30 to 50 percent of patients develop recurrent tumors within 
five years. 
Other research groups had worked with IL-12 as a potential 
alternative therapy for superficial bladder cancer. The drug  
had shown an ability to eliminate tumors, but a recent clinical 
study on patients with recurrent superficial bladder cancer was 
not successful. 
Working with mouse models, Zaharoff, Greiner and Hoffman 
designed a study that instilled treatments of BCG, IL-12 or the 
chitosan/IL-12 co-formulation into the bladder using a catheter. 
They found that chitosan improved delivery and bio-adhesion of 
interleukin 12. After four treatments, 88 to 100 percent of mice 
treated with chitosan/IL-12 were cured, meaning the tumors were 
eradicated. In contrast, only 38 to 60 percent of mice treated with 
IL-12 alone were cured. None of the mice treated with BCG alone 
were cured. 
“Antitumor responses following chitosan/IL-12 treatments were 
durable and provided complete protection from tumor re-chal-
lenge,” Zaharoff says.
These results excited Zaharoff, and he was motivated to under-
stand the mechanisms at work. Urinary analysis showed that chi-
tosan/IL-12 had induced multiple cytokines at levels significantly 
higher than either IL-12 alone or BCG. Tumor analysis following 
chitosan/IL-12 treatments revealed moderate to intense tumor 
infiltration by T cells, a group of white blood cells critical to the 
immune system, and macrophages, also a type of white blood cell. 
Bladder tissues from cured mice contained residual populations of 
immune cells that returned to baseline levels after several months.
What He’s Made Of
Although proud of his work at the National Cancer Institute, 
Zaharoff knew it was time to move on. All along, the plan was 
to procure an academic position at a university and establish his 
own lab. Having paid his dues in Schlom’s lab, Zaharoff accepted 
Left, Zaharoff combines chitosan with Interleukin-12, an agent that 
stimulates the body's immune system to attack cancerous tumors. Top 
right, chitosan/IL-12 mixture. Zaharoff examines a mouse (center top) 
and measures the diameter of a tumor (center bottom). Bottom right, 
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a position in the rapidly burgeoning biomedical engineering 
program at the University of Arkansas. He says positions at other 
institutions were attractive, but Arkansas offered resources and the 
kind of academic freedom he was seeking to build an eminent lab 
the way he envisioned it.
“My training phase was over,” he says. “It was time to become an 
investigator with my own lab and see what I’m made of.”
Without severing ties to Greiner and Schlom’s lab, Zaharoff 
came to the University of Arkansas in early 2009 and immediately 
began setting up shop in the Engineering Research Center at the 
Arkansas Research and Technology Park in south Fayetteville. 
Today the Laboratory of Vaccine and Immunotherapy Delivery 
occupies approximately 1,900 square feet of space in the 
Engineering Research Center. Inside the lab, Zaharoff directs  
and trains a group of researchers, from undergraduates to post-
doctoral fellows, who focus on vaccines and delivery systems 
for several types of cancer, including lung, breast, prostate and 
myeloma, in addition to bladder. They are also focusing on drug 
addiction, specifically a new vaccine that can induce the immune 
system to generate drug-specific antibodies. Zaharoff intends for 
all of this research to reach clinical trials within five years.
A New Standard of Care
Or at least be ready for clinical trials. Zaharoff is learning how 
political that process can be. He and Greiner thought clinical 
trials testing chitosan/IL-12 on patients with superficial bladder 
cancer were to begin in 2010, but those studies have been pushed 
back. He hopes they will begin in 2011, but he understands that 
these decisions will be made by trial clinicians and others at the 
U.S. Food and Drug Administration.
When clinical trials do begin, they will treat patients whose dis-
ease has returned after an initial treatment with BCG, the current 
standard of care. According to Research Support and Sponsored 
Programs, the university department that manages and tracks 
all public research funds, it will mark the first time that research 
from the University of Arkansas – which does not have a medical 
school – will have reached the medical clinical trial phase.
What are his hopes and expectations for the performance 
of chitosan/IL-12 in clinical trials? When asked this question, 
Zaharoff’s response is immediate and unequivocal: “I want it to be 
the new standard treatment of care for superficial bladder cancer.”
The Colorectal and Pancreatic Study
 
Zaharoff moves on. He is not the type of person who becomes 
complacent and waits around for others to gauge the success of 
his previous work, no matter how promising. For the past year, he 
and Greiner have applied chitosan/IL-12 to colorectal and pan-
creatic tumors in mice. 
Injections eradicated aggressive tumors. This study also includ-
ed three types of therapy. In addition to the chitosan/IL-12 co-
formulation, the researchers injected IL-12 only and combinations 
of chitosan with other cytokines. Administration of IL-12 alone  
eradicated less than 10 percent of established tumors, but  
the combination of chitosan/IL-12 caused complete tumor  
regression. Therapies with chitosan and other cytokines were  
not successful. 
Again, the immune systems of mice were stimulated by the 
extended presence of chitosan/IL-12 in the tumor microenviron-
ment. Specifically, Zaharoff found that the combination caused 
significant expansion of CD8+ T-cells and natural killer cells, two 
types of powerful immune cells. Depletion of these cells stopped 
anti-tumor activity. However, depletion of other important 
immune cells, CD4+ and Gr-1+ cells, had no impact on chitosan/
IL-12’s ability to eradicate tumors.
The colorectal and pancreatic study also revealed the unique 
power of immunotherapy compared to other methods of treating 
cancer. Traditional cancer therapies, such as surgery, radiation 
and chemotherapy, are passive approaches that do not eliminate 
metastasis after a treatment is stopped. Metastasis, or the spread-
ing of cancer from the original tumor site to other areas of the 
body via the circulatory or lymphatic systems, is responsible for 
more than 90 percent of all cancer fatalities. Zaharoff says that 
chitosan/IL-12 immunotherapy is an active approach that induces 
a massive immune response capable of “remembering” what a  
particular tumor cell looks like long after therapy is complete. As 
a result, if the tumor tries to recur in the same or distant place, 
the immune system will recognize it and destroy it.
This behavior – the memory and subsequent ability to stimulate 
the immune system as cancerous cells return – motivates Zaharoff 
and Greiner to test chitosan/IL-12 on metastatic cancer. In  
these cases, Zaharoff proposes to combine immunotherapy  
with surgery, to inject chitosan/IL-12 into a tumor before it is  
surgically removed. 
Training the Immune System
With metastatic cancer in mind, Zaharoff has turned his  
attention to breast cancer, which claims most of its victims after 
the cancer has spread to other areas of the body. Zaharoff is  
studying a model in mice in which tumors grow and metastasize 
in a pattern similar to cancer progression in women. Before  
surgically removing tumors from female mice, the researchers 
tested one of several vaccines that are intended to “train” the 
immune system to find and destroy metastases.
“This immunotherapy is not meant to replace surgery,” 
Zaharoff says. “In fact, we would still like to see all breast tumors 
removed. But it gives us a couple of weeks to ‘train’ the immune 
system before the surgery and thus reduce chances for recurrence 
or metastasis.”
In addition to the breast cancer study, researchers in Zaharoff’s 
lab are also pursuing projects focused on prostate cancer, myelo-
ma, lung cancer and drug addiction.
“By no means do we think this therapy is limited to colorectal, 
bladder and pancreatic cancers,” Zaharoff says. “We think this is  
a broadly applicable immunotherapy that may be used for the 
treatment of any injectable solid tumor.” n
Excited to Go to Work
Sometimes the indirect route is the best way to get 
to where you want to be, even if you don’t know exactly 
where that is. At least you know where you don’t want to 
be. This was how it worked for David Zaharoff. He start-
ed as a mechanical engineer. After finishing his bach-
elor’s degree at the University of Illinois, he watched his 
friends go off to Detroit and other places, where they 
earned good money. But Zaharoff wasn’t inspired by the 
types of problems – “fuel efficiency, aerodynamics, stuff 
like that” – that they were solving.
“All my friends went to work at Ford and GM, and 
they’re perfectly happy,” he says. “But I couldn’t see 
myself designing a luggage rack on a minivan. I wanted 
a bigger challenge.”
Questions he wanted to answer: Why does the human 
body randomly develop deadly diseases? How does the 
body respond to different types of biomaterials? Why 
are most drugs taken orally if they are meant to act at 
very specific locations within the body? What is the ideal 
way to treat cancer? These kinds of questions steered 
him toward biomedical engineering and landed him at 
Duke.
“These were problems I could identify with, problems 
that excited me,” Zaharoff says. “Because ultimately you 
have to be excited to go to work. If not, it makes for a 
long day.” n
Top left, cancer antigens encapsulated in polymer microspheres. Center left, histology and immune cell staining of bladder tissue from cured mice. 
Bottom left, mouse bladder cancer cells growing in culture. Right, graduate research assistant Bhanu Prasanth Koppolu uses a flow cytometer to 













If you talk very long to psychologists who study memory, 
big questions arise:  Do we make our memories or do our 
memories make us? Those vivid memories that we all have 
– did they actually happen? What about false memories?
By Barbara Jaquish
Memory?
What’s       a                
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Denise Beike and James Lampinen have studied mem-ory for decades in the lab and in the field. Each experiment 
they construct and conduct teases out 
one more clue to the mystery of memory. 
Much of Beike’s work has focused on auto-
biographical memory, the memories of life 
experiences. She has looked at emotional 
content and what it means for memories 
to be open or closed. 
Lampinen has studied memory gone 
wrong – mistaken memories or false mem-
ories – and memory focused on future 
actions, such as remembering the face of a 
fugitive or missing person. 
Do our memories make us?
Beike says there are 
two sides  
to this question:
“Are memories influ-
ential? Absolutely. But we 
are not the victims of our 
memories. We are not the 
passive recipients of our 
memories’ influence.”
Rather, Beike makes 
the case that we are in 
charge of our memories. 
People often think about 
memory as a static video 
recording that simply 
gets replayed. In fact, 
Beike said, memories are 
“flexible, reconstructed 
and error-filled.” With 
mutability comes power.
“Because memories are 
reconstructed and altered, if you know the 
healthy or productive or good way to think 
about things, you have the option to do what 
you want with your memories.”
In her research in autobiographical 
memory, Beike has seen people do just that. 
Autobiographical memory encompasses 
the simplest early memory of breaking your 
grandmother’s favorite cup as well as per-
sonal memories of a day that most people 
remember, like September 11, 2001. 
“Much of the reason we remember is 
because it causes us to have some kind of 
emotional experience. Memory helps us 
learn a lesson about the past, reminds us 
why we feel close to someone or makes 
us laugh when we think about something 
that happened,” Beike said. “I’ve been 
interested in how memory helps us adapt 
and adjust to experiences and how it influ-
ences future behavior.”
Closure and coping
Memories can either be open or closed. 
Open memories contain more emotional 
detail and arouse more agitated emotions 
than do closed memories. And, emotional 
content exists with both pleasant and 
unpleasant memories. Open and closed 
memories are not 
memories of different 
types of experiences; 
rather, they are differ-
ent ways of thinking 
about or responding to 
an experience.
“It doesn’t matter 
how long ago some-
thing happened, but if 
you remember it and 
it doesn’t pull at you 
emotionally, you have 
closure on it,” she said. 
“It’s under your con-
trol. You can choose 
to remember the emo-
tions or not.”
Brain-imaging 
studies have made 
this process clearer. 
Autobiographical memories aren’t neatly 
filed on a shelf of the brain like some kind 
of memory library. Instead, memories are 
composed of bits and pieces that come 
together in the hippocampus.
“Your brain goes searching within itself 
for all the little elements of the memory. 
What smells do I remember? Who was 
there? What did I see, and what did I 
hear? Then it bonds them together, and 
you say ‘oh, yes, I remember that day’,” 
Beike explains. “If your brain just decides 
it’s not going to go looking for the emo-
tional pieces, well then there you have it. 
They’re still there, but it just didn’t at that 
moment bring them in.”
Closure is just one way people have to ele-
vate or to reduce the importance of an event.
“I think we probably have a whole bas-
ketful of coping mechanisms that we don’t 
necessarily think about,” Beike said.
One coping mechanism is to shrink or 
stretch event boundaries, meaning that 
people can look at an event in a way that 
makes it more or less closely related to the 
self. For example, when your friend inter-
rupted you while you were telling a really 
good story, if that event is remembered 
as something that happened once on one 
day, it has little influence on how you view 
yourself and your friend. If you expand 
the boundary of the event to see your 
friend’s rudeness as the latest example 
of repeated disrespect for you, then the 
memory has more impact and becomes 
more focused on you.
Knowing that people have the option 
to do what they want with their memories 
is important for psychotherapy, particu-
larly for those who study and treat post-
traumatic stress disorder. Beike also sees 
implications for how people remember 
“the lumps and bumps of life” as well as 
the triumphs of life: 
“It’s not just that you’re a victim of cir-
cumstance and the environment. You can 
exercise your free will in how you remem-
ber those things, and the mere act of 
remembering in a different way changes 
you and changes what you do and changes 
how well adjusted you are.” 
Remembering unpleasant  
experiences with a sense of closure, Beike 
says, is the healthy and adaptive way to 
remember them.
What about false memories?
In his basic memory research, James 
Lampinen has looked in two directions: 
how do people come to have false memo-
ries that feel so real, and how do people 
avoid false memories.
Researchers in Lampinen’s lab have 
looked at false memories that are vivid 
and detailed, sometimes called phantom 
“Memories aren’t neatly filed on a shelf of the brain like some kind of memory library. Instead, memories are 
composed of bits and pieces that come together.”
Memory as Trauma
On September 12 and 13, 2001, Denise Beike 
recruited 111 University of Arkansas students 
to answer questions about how they were cop-
ing with the terrorist attacks of September 11. 
She collected responses again in October and 
December. 
Those who had attained closure were less 
likely to be ill or see the doctor in the three 
months after the attacks. Most attained closure 
despite being unable to “make sense” of what 
had happened.
Closure and making sense of an event are not 
the same thing, according to Beike. 
“Sometimes closure just means becoming sat-
isfied with the level of understanding you have,” 
she said.
People who had refused to let the attacks 
reshape their view of the world recovered more 
quickly than those who responded by extensively 
reevaluating their beliefs and perspectives. In 
fact, those who most successfully coped seemed 
to defy the idea that the events had changed 
their lives.
Memories of the September 11 attacks 
merged autobiographical memory and social 
event memory. The event was not treated like a 
memory in which there could be changes over 
time, but rather like a traumatic event, which 
was “rehearsed and refreshed with images that 
people watched over and over,” Beike said. 
The constant replaying of video of the attacks 
was akin to the way images replay in the mind 
of someone with post-traumatic stress disorder. 
Although people may choose to re-expose them-
selves to images in order to reduce the emotion-
al level of the memory and get closure, in reality 
such an approach doesn’t work, Beike said.
At some point, she notes, the television net-
works stopped replaying the video. 
“There was nothing positive to be gained 
from watching those planes hit those towers and 
watching those towers collapse,” she said. ■
memories  
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recollections. In one experiment, the 
researchers set up a room that looked like 
a graduate student’s office furnished with 
the usual office supplies and equipment 
but no stapler. When researchers tested 
participants about what had been in the 
room, people would say they remembered 
a stapler being in the office. The research-
ers took this one step farther and asked if 
they distinctly remembered a detail about 
the stapler and to describe it. 
“A surprising number of people indicat-
ed that, yes, they could remember details, 
such as the size, shape, color and location 
of the stapler,” Lampinen said.
In another experiment, participants 
listened to a tape of three different people 
reading a list of words that followed a 
theme, such as bed, rest, nap, snooze, 
slumber, all related to the word sleep, but 
the word sleep was never presented. When 
tested, many study participants not only 
said they’d heard the word sleep, but they 
identified the speaker who had said it. 
Lampinen calls this process “content 
borrowing.” When someone is retrieving 
a memory, at first the item feels familiar, 
and that feeling of familiarity leads them to 
search their memory for details.  They recall 
details from a different but related event 
that is close enough that it convinces them.
Thus, when the study participants are 
tested about the sleep-related words, they 
are borrowing details from other words that 
convince them that they heard the word 
sleep and that they can recall the particular 
person who said the word. In some cases, 
participants reported remembering the 
word because it had been said in a strident 
voice. That was another demonstration of 
borrowing. A word had been said in a stri-
dent voice, but it wasn’t the word sleep.
Mistaken witnesses
It may not matter whether you remem-
ber all the details of a cup you broke. 
Maybe it was blue, maybe flowered. But 
in other cases, the details are crucial, and 
vivid memories may lead you astray. At 
worst, a false memory could lead to the 
conviction of an innocent person. 
When it comes to mistaken identification 
in legal situations, Lampinen says there are 
two issues. First are the factors neither wit-
nesses nor criminal investigators can do any-
thing about, such as distance from the perpe-
trator and lighting. Also, research has shown 
that people are better at identifying people 
of their own race or ethnicity than people 
of other races or ethnicities. All that can be 
done is to inform the jury about these limita-
tions so they can take them into account. 
Other factors are under the control of 
the criminal justice system.
In a line-up that includes a suspect, 
police will include a certain number of foils, 
individuals who are not suspects and are 
known to be innocent. Studies of police 
records have shown that about 20 percent 
of the time, witnesses 
chose one of the foils. 
And, Lampinen points 
out, “We know that in 
one out of five actual 
criminal cases, witnesses 
choose an innocent 
person out of the 
lineup, because they 
choose one of the foils. 
Presumably, some per-
centage of suspects who 
are identified are also 
the wrong person.” 
If a sufficient number 
of foils are used, and 
the line-up is fair, even 
if witnesses are mistaken 
in their identification, 
they are more likely to 
mistakenly pick a foil 
than to mistakenly pick the suspect. The 
instructions given to the witness can make a 
big difference. It’s been shown that simply 
telling a witness ‘the perpetrator may or may 
not be in this line-up’ substantially decreases 
the chance of a false identification. 
For several years, Lampinen’s lab has 
researched the factors that affect confi-
dence judgments in identification. 
“The issue isn’t simply that witnesses 
make mistakes, but that witnesses make 
mistakes and they’re really confident that 
they’re correct,” Lampinen said.
The single largest cause of mistaken con-
victions is mistaken eyewitnesses, Lampinen 
says. Moreover, in cases where convictions 
have been over-turned with DNA evidence, 
around 75 percent of those cases have had 
a confident eyewitness. 
One area Lampinen has studied and 
continues to study is the effect of feed-
back. Witnesses are vulnerable to feedback 
effect. That is, if a witness makes an iden-
tification and gets confirmation – “Yep, 
that’s him. That’s the guy.” – the witness is 
more likely to feel extremely confident in 
the identification and in later interviews to 
indicate that they were confident all along. 
“Confidence is probably created after the 
fact and is not a direct 
memory of how confident 
you were at the time,” 
Lampinen said.
Lampinen plans to 
continue doing research 
on eyewitness confidence. 
For one, he is interested 
in investigating what 
happens to a witness’s 
confidence when an 
unreliable individual, 
such as a snitch, confirms 
the identification. He is 
also doing some basic 
research on the effect of 
environmental factors, 
such as distance, on the 
accuracy of identification.
His false memory work 
at this time is focused on 
developmental work in children, looking 
at memory monitoring and cognitive con-
trol. His study will examine those factors 
both in terms of brain function as children 
age and as related to experiences in school 
or seeing other people use their memory.
Memory in the future
How will those children Lampinen is study-
ing use their memories in a world in which 
cameras record every family event and many 
public streets? Beike says it is a very different 
world today, with people obsessively clicking 
their cell phones to record everything. Yet she 
questions how often people actually go back 
to all those photos.
“Even if we have the recorded informa-
tion, we won’t necessarily access it,” she 
said. “After all, we have our own memories 
to tell the story for us.” ■
In laboratory experiments, people remember details about a stapler that wasn’t there.
The Faces of  
Missing Children:  
Tips to Improve Recall
With prospective-person memory, people see 
a picture of a fugitive or of a missing child and 
try to remember the face, try to become eyewit-
nesses in the future. In the favorable conditions 
of a lab study, 20 to 60 percent of participants 
spot the missing person. In real-life field stud-
ies, the rate plunges to 3 percent. In research 
conducted at grocery stores, few customers could 
identify the faces of missing children right after 
leaving the store.
James Lampinen suggests two simple things 
people can do to improve their memory for the 
faces of missing children. First, he suggests, 
people should take a few minutes to look at the 
photos of missing children during the next visit 
to the supermarket, engaging in what is called 
“implementation intention.”
“Previous research has shown that if you 
repeat an intention to yourself three times out 
loud, you can dramatically increase doing what-
ever it is you intend to do,” Lampinen said. 
Lampinen suggested that people look at the 
faces in the posters holistically.
“One mistake we sometimes make is to try to 
memorize a face in the same way we memorize 
a string of words,” Lampinen said. “A string of 
words you can memorize one word at a time. 
With a face, you can’t just remember the eyes 
and then the nose and then the mouth. Rather, 
faces are best remembered as perceptual wholes. 
You have to take it all in. And, try to picture the 
child’s face in different situations.” ■
“
”
The issue isn’t  
simply that witnesses 
make mistakes, but 
that witnesses make 
mistakes and they’re 
really confident that 
they’re correct.
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Rule 6.10
By Andy Albertson
We all know the old saying, “Don’t talk about politics or 
religion.” Whoever came up with it must not have known any 
baseball fans, because surely she would have added “or the 
designated hitter rule.” 
Since 1973, Major League Baseball has seen its two leagues, 
the American League and the National League, play a slightly 
different form of the same game. The source of this discrepancy 
is the designated hitter rule. In the National League, the pitcher 
does his own batting. In the American League, a skilled hitter 
takes the place of the pitcher in the batting lineup.
29Spring 2011Research Frontiers28 Spring 2011Research Frontiers
words, do the benefits of the rule outweigh the moral hazard 
effect?
One of the most obvious benefits is increased offensive pro-
duction. According to the article, “during the first four seasons 
after implementation of the rule, the American League averaged 
1,640 more runs, 202 more home runs, and 19 more points in 
batting average, compared with the 1972 season. Indeed, the 
American League has led the National League in overall batting 
average every year since the adoption of the rule.” The increased 
offense has in turn increased attendance dramatically in the 
American League. 
Another benefit of the designated hitter rule is that it pro-
longs the careers of popular players, which also drives atten-
dance and allows for gradual recovery from injury. All-time 
greats like Hank Aaron and Ken Griffey, Jr., were able to  
continue playing even after age and injury had taken their toll 
on their bodies, by moving into the designated hitter role. The 
rigors of fielding are taken out of the equation, which also helps 
players who are recovering from injury. As the article points out, 
“After Mariners slugger Edgar Martinez suffered hamstring and 
knee injuries in 1993 and 1994, he came back as a designated 
hitter and made the All-Star roster in 1995, while batting an 
impressive .356 at the plate.”
The article also examines a frequent complaint about the  
designated hitter rule, that it lessens the strategy involved in 
baseball by eliminating the need for the manager to choose 
between letting his pitcher hit in a close game or bringing in  
a pinch hitter. On the surface, this appears to be a cost of the 
designated hitter rule, but Buehler and Calandrillo find that this 
is not necessarily the case. In fact, it might make pitching deci-
sions more difficult for managers. As former Angels manager 
Bobby Winkles said, “It was a great help when the pitcher used 
to bat because, even if you weren’t sure if he was tired, if he was 
up and you had a man on and were down by a run, you’d take 
him out. Now you try to make sure he’s tired and you might go 
just one man too long.”
Given the low incidence of injury from batters being hit by 
pitches and the bench-clearing brawls that sometimes accompa-
ny hit batsmen, the article concludes that this cost, while serious, 
does not outweigh the benefits the American League enjoys as a 
result of the designated hitter rule. 
So, if it works for the American League, wouldn’t it work 
for the National League? Not so fast. The article finds that the 
cost-benefit analysis would be different for the two leagues for a 
simple reason – National League fans have different preferences 
than American League fans. 
As Buehler and Calandrillo conclude their article:
“American League fans enjoy the increased offense that the des-
ignated hitter rule provides. National League fans enjoy pitching 
duels and the chance to see the manager struggle with the deci-
sion whether to pinch-hit for the pitcher in close games. Thus, 
this may be an instance in which fans should agree to disagree. As 
long as fans in each league are satisfied with the game under the 
existing rules, let’s play ball (and pass the Cracker Jacks).”
To most people, this probably doesn’t sound like a big deal. 
To a baseball fan, a calm, rational discussion of the designated 
hitter rule can escalate quickly into an argument, shouting, hurt 
feelings, fisticuffs, or worse. As a writer for Sports Illustrated once 
put it, “probably not since the Roman Catholic Church switched 
from Latin to English Masses has any break with tradition caused 
more vigorous argument in this country.” 
University of Arkansas law professor Dustin Buehler and 
University of Washington law professor Steve Calandrillo brave 
the waters and attempt to settle the debate once and for all in 
their article “Baseball’s Moral Hazard: Law, Economics, and the 
Designated Hitter Rule,” published in the Boston University Law 
Review. The article paints a detailed picture of the debate and 
then takes a law-and-economics approach to settling it.
So, how did Major League Baseball come to operate under 
two sets of rules? In the late ’60s and early ’70s, baseball was 
dominated by pitching. Runs were hard to come by, especially in 
the American League. Fans shied away, and in the 1972 season, 
the National League outdrew the American League by four  
million fans. Hoping to increase scoring and attendance, in 
1973, the American League adopted the designated hitter rule 
on a three-year trial basis.
The new rule was so successful in bringing offense and fans 
back to the American League that the League voted to make 
the change permanent in the 1976 season. National League 
fans decried the rule as disrespectful to baseball tradition and 
claimed it took the strategy out of the game. American League 
fans flocked to the stadiums to watch the runs pile up. 
Buehler and Calandrillo’s article focuses on another aspect of 
the debate – does the designated hitter rule create a moral haz-
ard? A moral hazard exists when a person behaves in a risky way 
because he doesn’t fear retribution. One risky, often rewarding, 
thing a pitcher can do is throw inside (close to the batter) to 
open up more of the strike zone or to simply hit the batter with 
a pitch. Hitting a batter grants a walk but often saves a run. And, 
it can sometimes lead to injuries or even bench-clearing brawls. 
In addition, hitting a batter with a pitch often results in the 
other team’s pitcher serving up retribution by hitting a player on 
the other team.
In the case of the designated hitter rule, it has been demon-
strated that American League pitchers are more likely to hit 
batters with their pitches, in part because the pitchers do not 
have to worry about being hit with a pitch themselves since they 
won’t be batting. On average, American League pitchers have 
been 10 to 15 percent more likely to hit batters, and by 2004, the 
National League has exceeded the hit-batter rate only four times 
in 31 seasons. This suggests that the designated hitter rule has 
created a moral hazard. 
Though the discrepancy between hit batsmen in the National 
League and American League is shrinking due to factors such 
as league expansion and the “double warning” or “one free hit” 
rule, Buehler and Calandrillo conclude there is clearly a cost to 
the designated hitter rule, namely, the moral hazard it creates. 
To settle the debate, they use a cost-benefit analysis. In other 
Any League may elect to use the Designated Hitter Rule.
(a)  In the event of inter-league competition between clubs of Leagues 
using the Designated Hitter Rule and clubs of Leagues not using 
the Designated Hitter Rule, the rule will be as follows:
 1.  In World Series or exhibition games, the rule will be used or 
not used as is the practice of the home team.
 2.  In All-Star games, the rule will only be used if both teams and 
both Leagues so agree.
(b)  The Rule provides as follows:
	 •		A	hitter	may	be	designated	to	bat	for	the	starting	pitcher	and	all	
subsequent pitchers in any game without otherwise affecting the 
status of the pitcher(s) in the game.
	 •		A	Designated	Hitter	for	the	pitcher	must	be	selected	prior	to	the	
game and must be included in the lineup cards presented to the 
Umpire in Chief.
	 •		The	designated	hitter	named	in	the	starting	lineup	must	come	to	
bat at least one time, unless the opposing club changes pitchers.
	 •		It	is	not	mandatory	that	a	club	designate	a	hitter	for	the	pitcher,	
but failure to do so prior to the game precludes the use of a 
Designated Hitter for that game.
	 •		Pinch	hitters	for	a	Designated	Hitter	may	be	used.	Any	substitute	
hitter for a Designated Hitter becomes the Designated Hitter. A 
replaced Designated Hitter shall not re-enter the game in any 
capacity.
	 •		The	Designated	Hitter	may	be	used	defensively,	continuing	to	bat	
in the same position in the batting order, but the pitcher must 
then bat in the place of the substituted defensive player, unless 
more than one substitution is made, and the manager then must 
designate their spots in the batting order.
	 •		A	runner	may	be	substituted	for	the	Designated	Hitter	and	the	
runner assumes the role of Designated Hitter. A Designated Hitter 
may not pinch run.
	 •		A	Designated	Hitter	is	“locked”	into	the	batting	order.	No	multiple	
substitutions may be made that will alter the batting rotation of 
the Designated Hitter.
	 •		Once	the	game	pitcher	is	switched	from	the	mound	to	a	defensive	
position this move shall terminate the Designated Hitter role for 
the remainder of the game.
	 •		Once	a	pinch	hitter	bats	for	any	player	in	the	batting	order	and	
then enters the game to pitch, this move shall terminate the 
Designated Hitter role for the remainder of the game.
	 •		Once	the	game	pitcher	bats	for	the	Designated	Hitter	this	move	
shall terminate the Designated Hitter role for the remainder of the 
game. (The game pitcher may only pinch-hit for the Designated 
Hitter).•		
	 •		Once	a	Designated	Hitter	assumes	a	defensive	position	this	move	
shall terminate the Designated Hitter role for the remainder of 
the game. A substitute for the Designated Hitter need not be 
announced until it is the Designated Hitter’s turn to bat.
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Dark Age Bodies: Gender and Monastic 
Practice in the Early Medieval West 
Lynda L. Coon
University of Pennsylvania Press
In this book, history professor 
Lynda L. Coon reconstructs the  
gender ideology of monastic mascu-
linity through an investigation  
of early medieval readings of the 
body.
Focusing on the Carolingian era 
(ca. 751-987), Coon evaluates the 
ritual and liturgical performances  
of monastic bodies within the  
imaginative landscapes of same-sex 
ascetic communities in northern 
Europe. She demonstrates how  
the priestly body plays a role in  
shaping major aspects of Carolingian 
history, such as the revival of clas-
sicism, movements for clerical 
reform and church-state relations. 
Carolingian churchmen consistently 
exploited monastic constructions  
of gender to assert the power of  
the monastery. 
Focusing on the body, architecture 
and ritual practice, the book draws 
from visual and textual materials, 
including poetry, grammar manuals, 
rhetorical treatises, biblical exegesis, 
monastic regulations, hagiographies, 
illuminated manuscripts, building 
plans, and cloister design. Dark  
Age Bodies brings together scholar-
ship in architectural history and  
cultural anthropology with works  
in religion, classics and gender 
to present a reconsideration of 
Carolingian culture.
Mammal Teeth:  
Origin, Evolution, and Diversity
Peter Ungar
Johns Hopkins University Press
Few people think about the 400 
million years of evolution that took 
place before they could chomp on 
a carrot, but anthropologist Peter 
Ungar does, and he’s written a book 
about it.
First Ungar looks at why mammals 
developed teeth in the first place. 
He examines the tension between 
the feeder and food. Developing 
teeth meant being able to fracture 
food into easily digestible pieces and 
allowed mammals to survive in cold 
climates and become active at night. 
The section discusses how teeth 
have evolved through the ages. The 
first tooth-like structures date back 
half a billion years. Ungar looks at 
the evolution of jaws, teeth, chewing 
muscles and the bony palate that 
separates chewing and breathing.
He also explores “early experi-
ments,” or animals with unusual 
tooth formations that don’t have 
any descendants alive today, like the 
saber-tooth tiger.
Finally, Ungar provides a “who’s-
who” of the mammalian tooth world, 
offering up, a summary of the basic 
ecology of groups, where they live, 
what they eat, and a tooth-by-tooth 
description of the mouth of a rep-
resentative species. This description 
includes hand-drawn illustrations, 
which Ungar drew from museum 
specimens all over the world.
African Americans in Georgia:  
A Reflection of Politics and  
Policy in the New South
Edited by Pearl K. Ford
Mercer University Press
In the New South, access to voting 
has been cited as a measure of prog-
ress. But look at other factors and a 
different story emerges, according to 
political scientist Pearl K. Ford. 
Ford brought together essays by 
diverse scholars for a comprehensive 
study of politics and public policy 
issues with implications for African 
Americans in Georgia. Chapters 
examine the systemic barriers to 
political representation and the 
public policies that adversely impact 
quality of life for African Americans. 
Ford introduced the volume with 
discussion of Georgia in the New 
South. The idea of a New South 
attempts to separate the South of 
today from a history of racial  
violence and an economy dependent 
on slavery and later on the exploita-
tion of people of color. Georgia, 
she wrote, is known as progressive 
because of the dynamics of the met-
ropolitan area of Atlanta. 
However, electoral gains have not 
necessarily translated to equity in 
education, health and criminal jus-
tice. The ninth most populous state, 
Georgia’s economy is among the 
largest in the country. Yet, it ranks 
40th in overall health status, and 
African Americans bear the brunt  
of the burden of poor health and 
limited access to health care.
Unhealthy Cities: Poverty, Race, and 
Place in America
Kevin Fitzpatrick and Mark LaGory
Rutledge Press
Place matters when it comes to 
health, according to sociologist 
Kevin Fitzpatrick.
In Unhealthy Cities, Fitzpatrick 
and co-author Mark LaGory of 
the University of Alabama at 
Birmingham drew from the social 
sciences and public health fields to 
examine the role that place and poli-
cy play in the health of Americans.
In urban areas, a single zip code 
digit can make a big difference in 
life expectancy. More than 9 mil-
lion people live in more than 3,000 
high-poverty neighborhoods in the 
United States.
Studies have established a relation-
ship between a concentration of fast-
food restaurants in poor, predomi-
nantly minority neighborhoods and 
health problems among residents. 
These neighborhoods may not have 
one grocery store offering nutritious 
food or safe places to exercise. 
In the conclusion, Fitzpatrick and 
LaGory note that cities in the United 
States have become increasingly 
unhealthy over the past 50 years.
“Without a comprehensive  
place-based strategy to address the 
health needs of the at-risk, under-
served, and unprotected in the 
urban core,” they wrote, “America 
will continue to be a society plagued 
by the contradiction of great wealth 
and mediocre health.”
Remembrances in Black 
Personal	Perspectives	of	the	African	
American Experience at the University 
of	Arkansas	1940s–2000s
Charles F. Robinson II  
and Lonnie R. Williams
University of Arkansas Press
With the admittance in 1948 
of Silas Hunt to the University of 
Arkansas Law School, the university 
became the first southern public 
institution of higher education to 
officially desegregate without being 
required to do so by court order. 
The process was difficult, but an 
important first step had been taken. 
Other students followed in Silas 
Hunt’s footsteps. Remembrances in 
Black is an oral history that gath-
ers the personal stories of African 
American faculty, staff and students 
at the state’s flagship institution.
These stories illustrate the 
anguish, struggle, and triumph  
of individuals who had their lives 
indelibly marked by their experi-
ences at the school. Organized 
chronologically over 60 years, this 
book illustrates how people of color 
navigated both the evolving campus 
environment and that of the city  
of Fayetteville in their attempt to 
fulfill personal aspirations. Their 
stories demonstrate that the process 
of desegregation proved painfully 
slow to those who chose to challenge 
the forces of exclusion. Also, the 
remembrances question the extent 
to which desegregation has been 
fully realized.
Sex, Violence, and the Avant Garde 
Anarchism in Interwar France
Richard Sonn
Pennsylvania State University Press
In this book, history professor 
Richard Sonn argues that by the end 
of World War I, the conflict between 
anarchism and the state had been 
eclipsed by the competing forces of 
liberalism, fascism and communism.
To combat their slide into irrel-
evance, French anarchists, especially 
those called individualists, redirected 
their attentions from violent revolu-
tion and general strikes to ethical 
issues that focused on personal 
liberation. Chief among these issues 
was sexual freedom, meant not only 
for the sake of pleasure but to under-
mine the authoritarian family, bul-
wark of the patriarchal state.
Sonn approaches the French anar-
chist movement during this period 
from a socio-cultural perspective, 
considering the relationship between 
anarchism and the artistic avant-
garde, political violence and terror-
ism, sexuality and sexual politics, and 
gender roles. He shows that, anar-
chism in theory and practice played 
a significant role in the culture of 
interwar France.
Martin Jay of the University of 
California, Berkeley says, “Drawing 
on a wealth of new sources and a 
lifetime immersion in the history of 
European anarchism, Richard Sonn 
has fashioned a fresh and arresting 
account of the libertarian and liber-
tine left in France between the wars.”
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What Causes Soda Pop to Fizz?  
And Why Does it Lose its Fizz?
Bill Durham, professor and chair of the department  
of chemistry and biochemistry, replies:
Carbonated beverages are prepared by dissolving carbon dioxide  
gas in the water that makes up the bulk of most beverages. Carbon 
dioxide is not very soluble in water and only a small amount will  
dissolve naturally. This amount is not sufficient to alter the taste or 
provide fizz. However, if the carbon dioxide is forced into the liquid 
by increasing the pressure of the carbon dioxide in the container, much 
more will dissolve. The pressure used is around 100 pounds per square 
inch. As long as the pressure is maintained, the carbon dioxide will 
remain dissolved. When the cap of a carbonated beverage is removed, 
the pressure of carbon dioxide over the beverage is reduced to almost 
zero. Under these conditions, the carbon dioxide becomes less soluble 
in the beverage and it will be released. The process of releasing the 
gas can be slow or fast. Once all of the carbon dioxide is released, the 
beverage becomes flat and contains about the same amount of carbon 
dioxide it would if we just allowed the carbon dioxide naturally in the 
atmosphere to dissolve in the beverage.
Why Has There Been A Seeming 
Sudden Upsurge of Bed Bugs?
Allen Szalanski, professor of entomology in the 
Dale Bumpers College of Agricultural, Food and 
Life Sciences, replies:
Since the late 1970s, bed bugs have undergone a resurgence 
that became widespread in the late 1990s, and it seems to be 
global across the developed world. Reasons for this resurgence 
may include increased long-range airline travel, the ability of 
bed bugs to disperse locally, reduction in the use of residual 
insecticides around structures, and movement of bed bugs 
from birds and bats to humans. Our research has revealed  
that bed bugs in Arkansas are highly resistant to DDT. We  
also have found that human DNA can be recovered from bed 
bugs for up to 90 days, and this DNA could then be used for 
forensic purposes.
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